功能高分子材料教育部重点实验室

近期发表论文
当前位置: 首页 > 科技创新 > 近期发表论文 > 正文

史林启课题组 | CHEMICAL ENGINEERING JOURNAL

发布人:    发布时间:2023/02/06   浏览次数:

Protection of DNase in the shell of a pH-responsive, antibiotic-loaded micelle for biofilm targeting, dispersal and eradication

作者:

Tian, S (Tian, Shuang) [1] , [2] , [3] , [4] ; Su, LZ (Su, Linzhu) [1] , [2] , [3] , [4] ; An, YL (An, Yingli) [1] , [2] ; van der Mei, HC (van der Mei, Henny C.) [3] , [4] ; Ren, YJ (Ren, Yijin) [5] , [6] ; Busscher, HJ (Busscher, Henk J.) [3] , [4] ; Shi, LQ (Shi, Linqi) [1] , [2]

CHEMICAL ENGINEERING JOURNAL

452

子辑

4

文献号

139619

DOI

10.1016/j.cej.2022.139619

出版时间

JAN 15 2023

已索引

2023-01-22

文献类型

Article

摘要

DNase can break down the extracellular matrix that keeps infectious bacterial biofilm together through cleavage of eDNA. Herewith, biofilm bacteria can become dispersed to assist antibiotic eradication but this has hitherto remained an in vitro possibility. In vivo DNase is rapidly broken down in blood, impeding blood-injection of DNase combined with antibiotics to cure bacterial infections. Herein, we report the synthesis of pH-responsive, self-targeting micelles self-assembled from a solution of poly(ethylene glycol)-block-poly(epsilon-caprolactone) (PEG-b- PCL) and poly(epsilon-caprolactone)-block-poly(amino ester) (PCL-b-PAE) with DNase conjugated to PAE-blocks. At physiological pH, this conjugation protected DNase inside the micellar shell, while PEG prevented adsorption of blood-borne proteins to the micelles. PAE became positively-charged below pH 6.4 facilitating self-targeting to an infectious biofilm. Simultaneously, PAE became hydrophilic and stretched to expose DNase upon accumu-lation in an infectious S. aureus biofilm where it degraded the biofilm matrix. PEG/PAE-DNase micelles internally core-loaded with ciprofloxacin significantly better eradicated murine pneumonia after blood-injection than ciprofloxacin-loaded PEG/PAE micelles without conjugated DNase or ciprofloxacin free in solution. Considering that DNase is clinically approved for use in cystic fibrosis patients, this paves the way for clinical translation of ciprofloxacin-loaded, PEG/PAE-DNase micelles for the treatment of pneumonia and other infections that can be reached through self-targeting after blood-injection.